Stay updated on Filgotinib Combo in RA Patients Inadequate Response Clinical Trial
Sign up to get notified when there's something new on the Filgotinib Combo in RA Patients Inadequate Response Clinical Trial page.

Latest updates to the Filgotinib Combo in RA Patients Inadequate Response Clinical Trial page
- Check6 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of showing the study details. This indicates the record is currently inaccessible to users.SummaryDifference18%

- Check13 days agoChange DetectedThe site's software version was updated from v3.6.6 to v3.7.0. This marks a new release of the underlying platform and does not alter page content.SummaryDifference0.0%

- Check20 days agoChange DetectedTel Litwinsky, Israel was added as a collaborator on the study page. Rheumatoid arthritis and the MedlinePlus Genetics related topic, along with the Qiryat Krinitzi, Israel location, were removed from the page.SummaryDifference0.1%

- Check27 days agoChange DetectedA new study site in Qiryat Krinitzi, Israel was added and Tel Litwinsky, Israel was removed, altering the enrollment locations. The page revision was updated to v3.6.6, replacing the previous version.SummaryDifference0.1%

- Check34 days agoChange DetectedAdded funding metadata (2016 U.S. NIH Grant/Contract) and a related topics reference (MedlinePlus Genetics). Reaffirmed the study’s core condition (rheumatoid arthritis).SummaryDifference0.1%

- Check41 days agoChange DetectedRheumatoid arthritis and related topic links have been removed from the page, reducing the visible disease context and related information accessible from the page.SummaryDifference0.1%

Stay in the know with updates to Filgotinib Combo in RA Patients Inadequate Response Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib Combo in RA Patients Inadequate Response Clinical Trial page.